3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
22
Carcinoma, Hepatocellular
15
Small Cell Lung Carcinoma
11
Triple Negative Breast Neoplasms
9
Neoplasms
8
Colorectal Neoplasms
6
Breast Neoplasms
6
Urinary Bladder Neoplasms
5
Lung Neoplasms
5
Carcinoma, Renal Cell
5
Ovarian Neoplasms
4
Carcinoma, Transitional Cell
3
Carcinoma
3
Uterine Cervical Neoplasms
2
Prostatic Neoplasms
2
Melanoma
2
Colonic Neoplasms
2
Venous Thrombosis
1
Urologic Neoplasms
1
Stomach Neoplasms
1
Squamous Non-Small Cell Lung Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Diseases
1
Rectal Neoplasms
1
Radiation Pneumonitis
1
Prostatic Neoplasms, Castration-Resistant
1
Peritoneal Neoplasms
1
Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer
1
Non-Squamous Non-Small Cell Lung Cancer
1
Non-Small-Cell Lung
1
Interventions
Carboplatin
8
Paclitaxel
7
Hyperthermic Intraperitoneal Chemotherapy
7
Bevacizumab
4
liposomal doxorubicin
3
Gemcitabine
3
Oxaliplatin
2
Neoadjuvant Therapy
2
relacorilant
1
phenoxodiol
1
pembrolizumab
1
oregovomab
1
olaparib
1
nintedanib
1
lobaplatin
1
lanreotide
1
epothilone B
1
atezolizumab
1
Trabectedin
1
Topotecan
1
Therapeutics
1
Surgical Procedures, Operative
1
Saline Solution
1
Leucovorin
1
Letrozole
1
Laparotomy
1
Laparoscopy
1
LAIF 900
1
Hypericum extract LI 160
1
Glucose
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Peritoneal Neoplasms
×
atezolizumab
×
Clear all
NCT03038100
2023-02-17
IMagyn050
Hoffmann-La Roche
Phase 3
Completed
1,301 enrolled
22 charts